Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 30, 1999

Study Completion Date

September 30, 2000

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Inhaled human insulin

Trial Locations (36)

Unknown

Pfizer Investigational Site, Burlingame

Pfizer Investigational Site, Irvine

Pfizer Investigational Site, Newport Beach

Pfizer Investigational Site, San Diego

Pfizer Investigational Site, San Francisco

Pfizer Investigational Site, Tustin

Pfizer Investigational Site, Hartford

Pfizer Investigational Site, Washington D.C.

Pfizer Investigational Site, Atlanta

Pfizer Investigational Site, Stockbridge

Pfizer Investigational Site, Chicago

Pfizer Investigational Site, Lexington

Pfizer Investigational Site, Columbia

Pfizer Investigational Site, St Louis

Pfizer Investigational Site, Omaha

Pfizer Investigational Site, Albuquerque

Pfizer Investigational Site, Buffalo

Pfizer Investigational Site, Manhasset

Pfizer Investigational Site, New Hyde Park

Pfizer Investigational Site, New York

Pfizer Investigational Site, Greenville

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Austin

Pfizer Investigational Site, Dallas

Pfizer Investigational Site, Irving

Pfizer Investigational Site, San Antonio

Pfizer Investigational Site, Charlottesville

Pfizer Investigational Site, Renton

Pfizer Investigational Site, Calgary

Pfizer Investigational Site, Winnipeg

Pfizer Investigational Site, St. John's

Pfizer Investigational Site, Halifax

Pfizer Investigational Site, London

Pfizer Investigational Site, Toronto

Pfizer Investigational Site, Laval

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY